JWM
PACB icon

JPL Wealth Management’s Pacific Biosciences PACB Stock Holding History

JPL Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Hold
40
– – ﹤0.01% 1676
2026
Q1 		$53 Buy
+40
New +$72 ﹤0.01% 1501
2025
Q4 		– Sell
-40
Closed -$52 – 815
2025
Q3 		$52 Buy
+40
New +$54 ﹤0.01% 1179

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JPL Wealth Management's PACB Position: Q2 2026 in Review

JPL Wealth Management held its Pacific Biosciences (PACB) position steady in Q2 2026 at 40 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

JPL Wealth Management first reported a position in PACB in Q3 2025 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • JPL Wealth Management held 40 shares of Pacific Biosciences worth $68 as of Q2 2026.
  • JPL Wealth Management left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1676 holding.
  • JPL Wealth Management first reported a position in Pacific Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.